Taken together with the results of CCLE and TCGA pan-cancer analysis, BDNF was commonly overexpressed in digestive cancers such as esophageal, stomach, colon, and pancreatic cancers, which indicated that BDNF may serve as a potential regulatory mechanism in tumor progression and patient prognosis. The gene discussed is BDNF; the disease is familial pancreatic carcinoma.